Table 2

Bivariate association of high-sensitivity cardiac troponin I with study covariates among controls (n=1135)

Quartile I (n=287)Quartile II (n=280)Quartile III (n=286)Quartile IV (n=282)p Value
Age, mean (SD)62.8 (6.8)62.5 (7.4)60.7 (8.7)62.5 (7.7)0.004
Female, n (%)141 (49.1)138 (49.3)142 (49.7)137 (48.6)1.0
Race/ethnicity, n (%)
 White186 (64.8)179 (63.9)177 (61.9)163 (57.8)0.01
 Black15 (5.2)18 (6.4)27 (9.4)41 (14.5)
 Hispanic/Latino32 (11.2)32 (11.4)26 (9.1)28 (9.9)
 Asian33 (11.5)27 (9.6)25 (8.7)18 (6.4)
 Other/mixed21 (7.3)24 (8.6)31 (10.8)32 (11.4)
Education level, n (%)
 Less than college144 (50.2)131 (46.8)151 (52.8)146 (51.8)0.5
 College or higher143 (49.8149 (53.2135 (47.2136 (48.2
Smoking status, n (%)
 Never128 (44.6)129 (46.1)121 (42.3)134 (47.5)0.06
 Former137 (47.7133 (47.5125 (43.7124 (44.0
 Current22 (7.718 (6.440 (14.024 (8.5
Diabetes mellitus, n (%)51 (17.8)37 (13.2)39 (13.6)62 (22.0)0.02
Body mass index (kg/m2), mean (SD)26.7 (4.8)27.8 (5.1)28.4 (5.7)30.2 (6.6)<0.0001
Hypertension, n (%)100 (34.8)110 (39.3)120 (42.0)167 (59.2)<0.0001
LDL-C (mg/dL), mean (SD)115.8 (30.6)120.9 (28.6)128.3 (31.5)128.2 (34.6)<0.0001
HDL-C (mg/dL), mean (SD)57.5 (17.3)54.9 (15.9)53.3 (15.4)53.8 (15.5)0.01
Triglycerides (mg/dL), median (IQR)102.0 (74.0–161.0)109.0 (78.5–159.5)113.5 (81.0–152.0)119.5 (84.0–162.0)0.07
Cholesterol lowering drugs, n (%)62 (21.6)50 (17.9)57 (19.9)67 (23.2)0.4
C reactive protein (mg/dL), median (IQR)1.4 (0.5–3.2)1.4 (0.6–3.0)1.5 (0.7–3.0)1.8 (0.8–4.4)<0.01
Estimated glomerular filtration rate (mL/min/1.73 m2), n (%)
 <6023 (7.7)18 (6.4)21 (7.3)41 (14.5)0.006
 60–89148 (51.6)144 (51.4)142 (49.7)151 (53.6)
 90–13066 (23.0)70 (25.0)69 (24.1)66 (23.4)
 >1304 (1.4)6 (2.1)8 (2.8)2 (0.7)
 Missing47 (16.4)42 (15.0)46 (16.1)22 (7.8)
10-year Framingham risk score, median (IQR)5.7 (1.9–12.1)7.1 (2.0–13.8)7.0 (1.7–15.1)8.2 (2.3–15.6)0.02